Medtronic plc – NYSE:MDT
Medtronic stock price today
$89.97
+9.23
+11.43%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
Medtronic stock price monthly change
+3.58%
month
Medtronic stock price quarterly change
+3.58%
quarter
Medtronic stock price yearly change
-2.04%
year
Medtronic key metrics
Market Cap | 103.49B |
Enterprise value | 130.46B |
P/E | 24.14 |
EV/Sales | 3.95 |
EV/EBITDA | 14.19 |
Price/Sales | 3.13 |
Price/Book | 2.13 |
PEG ratio | 2.31 |
EPS | 3.29 |
Revenue | 32.94B |
EBITDA | 8.60B |
Income | 4.37B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 13% |
Oper. margin | 17.83% |
Gross margin | 62.65% |
EBIT margin | 17.83% |
EBITDA margin | 26.11% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMedtronic stock price history
Medtronic stock forecast
Medtronic financial statements
Average Price Target
$95.4
Potential upside: 6.03%
Analysts Price target
Financials & Ratios estimates
| Jan 2023 | 7.72B | 1.22B | 15.81% |
|---|---|---|---|
| Apr 2023 | 8.54B | 1.17B | 13.8% |
| Jan 2024 | 8.08B | 1.32B | 16.34% |
| Apr 2024 | 8.58B | 654M | 7.61% |
3.45%
Yield TTM
| Payout ratio | 84.54% |
|---|
| 2020 | 2.17% |
|---|---|
| 2021 | 1.77% |
| 2022 | 2.41% |
| 2023 | 2.99% |
| 2024 | 3.46% |
| Jan 2023 | 94134000000 | 42.51B | 45.17% |
|---|---|---|---|
| Apr 2023 | 90948000000 | 39.28B | 43.19% |
| Jan 2024 | 90836000000 | 38.84B | 42.76% |
| Apr 2024 | 89981000000 | 39.56B | 43.97% |
| Jan 2023 | 1.57B | -287M | -2.13B |
|---|---|---|---|
| Apr 2023 | 2.46B | -475M | -4.89B |
| Jan 2024 | 2.47B | -707M | -1.5B |
| Apr 2024 | 2.77B | -696M | -2.35B |
Medtronic alternative data
What is mobile apps rank?
MiniMed™ Mobile US
| Platform: | Android |
| Store: | Google Play  |
| Type: | Free |
| Market: | United States |
Category:
| Nov 2023 | 187 |
|---|---|
| Oct 2024 | 188 |
Category:
| Jul 2024 | 357 |
|---|
Medtronic
| 9 Jul 2023 | 51 |
|---|---|
| 16 Jul 2023 | 58 |
| 23 Jul 2023 | 52 |
| 30 Jul 2023 | 52 |
| 6 Aug 2023 | 53 |
| 13 Aug 2023 | 55 |
| 20 Aug 2023 | 58 |
| 27 Aug 2023 | 55 |
| 3 Sep 2023 | 54 |
| 10 Sep 2023 | 55 |
| 17 Sep 2023 | 48 |
| 24 Sep 2023 | 52 |
| 1 Oct 2023 | 52 |
| 8 Oct 2023 | 46 |
| 15 Oct 2023 | 53 |
| 22 Oct 2023 | 53 |
| 29 Oct 2023 | 50 |
| 5 Nov 2023 | 42 |
| 12 Nov 2023 | 37 |
| 19 Nov 2023 | 47 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Sep 2023 | 2,034 |
|---|---|
| Oct 2023 | 2,273 |
| Nov 2023 | 1,969 |
| Dec 2023 | 1,911 |
| Jan 2024 | 1,592 |
| Feb 2024 | 1,553 |
| Apr 2024 | 1,403 |
| May 2024 | 1,503 |
| Jun 2024 | 1,693 |
| Jul 2024 | 1,790 |
| Dec 2024 | 1,051 |
| Jan 2025 | 880 |
| Feb 2025 | 1,020 |
| May 2025 | 1,095 |
| Jul 2025 | 1,315 |
| Aug 2025 | 1,371 |
| Sep 2023 | 95,000 |
|---|---|
| Oct 2023 | 95,000 |
| Nov 2023 | 95,000 |
| Dec 2023 | 95,000 |
| Jan 2024 | 95,000 |
| Feb 2024 | 95,000 |
| Mar 2024 | 95,000 |
| Apr 2024 | 95,000 |
| May 2024 | 95,000 |
| Jun 2024 | 95,000 |
| Jul 2024 | 95,000 |
Medtronic other data
78.82%
-0.69%
of MDT is owned by hedge funds
2.01K
+11
1.06B
-13.28M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jul 2023 | 0 | 7514 |
| Aug 2023 | 0 | 12352 |
| Dec 2023 | 0 | 4997 |
| Feb 2024 | 0 | 30695 |
| Apr 2024 | 0 | 854 |
| Jun 2024 | 0 | 19113 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | WALL BRETT A. officer: EVP & Pres Neuroscience | Ordinary Shares | 5,311 | N/A | N/A | ||
Option | WALL BRETT A. officer: EVP & Pres Neuroscience | Performance Share Units | 5,311 | N/A | N/A | ||
Option | WALTER MATTHEW R. officer: SVP, Chief HR Officer | Ordinary Shares | 684 | N/A | N/A | ||
Option | WALTER MATTHEW R. officer: SVP, Chief HR Officer | Performance Share Unit | 684 | N/A | N/A | ||
Option | SMITH GREGORY L officer: EVP Global Ops & Suppl.. | Ordinary Shares | 3,490 | N/A | N/A | ||
Option | SMITH GREGORY L officer: EVP Global Ops & Suppl.. | Performance Share Units | 3,490 | N/A | N/A | ||
Option | SALMON SEAN officer: EVP & President Cardio.. | Ordinary Shares | 5,462 | N/A | N/A | ||
Option | SALMON SEAN officer: EVP & President Cardio.. | Performance Share Units | 5,462 | N/A | N/A | ||
Option | PARKHILL KAREN L officer: EVP & Ch.. | Ordinary Shares | 7,132 | N/A | N/A | ||
Option | PARKHILL KAREN L officer: EVP & Ch.. | Ordinary Shares | 7,132 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q3 2024 20 Feb 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 8 Dec 2023 | Q2 2024 Earnings Call Transcript |
| Q4 2024 21 Nov 2023 | Q4 2024 Earnings Call Transcript |
| Q1 2024 22 Aug 2023 | Q1 2024 Earnings Call Transcript |
GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom
Abbott Laboratories: Proactive, Adaptive, Solid
Abbott Laboratories: FreeStyle Libre CGMs And EPD Business Driving Positive Momentum
Medtronic: Margin Inflection With Diabetes Spin - Key Drivers
Medtronic: Eyes On The Pipeline And Spin, Shares Still Cheap
LeMaitre Vascular: Scaling Nicely As Global Demand Builds
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
Beta Bionics: A Sugar Rush For This IPO
Abbott Laboratories: Strong Q4 Results And Bullish Outlook
-
What's the price of Medtronic stock today?
One share of Medtronic stock can currently be purchased for approximately $89.97.
-
When is Medtronic's next earnings date?
Unfortunately, Medtronic's (MDT) next earnings date is currently unknown.
-
Does Medtronic pay dividends?
Yes, Medtronic pays dividends and its trailing 12-month yield is 3.46% with 85% payout ratio. The last Medtronic stock dividend of $0.63 was paid on 14 Jan 2022.
-
How much money does Medtronic make?
Medtronic has a market capitalization of 103.49B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.64% to 32.36B US dollars.
-
What is Medtronic's stock symbol?
Medtronic plc is traded on the NYSE under the ticker symbol "MDT".
-
What is Medtronic's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Medtronic?
Shares of Medtronic can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Medtronic's key executives?
Medtronic's management team includes the following people:
- Mr. Geoffrey Straub Martha Chairman & Chief Executive Officer(age: 55, pay: $4,090,000)
- Ms. Karen L. Parkhill EVice President, Chief Financial Officer, IT & Enterprise Excellence(age: 60, pay: $3,290,000)
- Mr. Bradley E. Lerman Senior Vice President, Gen. Counsel & Corporation Sec.(age: 69, pay: $2,830,000)
- Mr. Robert John White Executive Vice President & Pres of Medical Surgical Portfolio(age: 62, pay: $2,660,000)
- Dr. Richard E. Kuntz M.D., M.Sc. Senior Vice President and Chief Medical & Scientific Officer(age: 68, pay: $2,610,000)
-
How many employees does Medtronic have?
As Jul 2024, Medtronic employs 95,000 workers.
-
When Medtronic went public?
Medtronic plc is publicly traded company for more then 52 years since IPO on 2 May 1973.
-
What is Medtronic's official website?
The official website for Medtronic is medtronic.com.
-
How can i contact Medtronic?
Medtronic can be reached via phone at +353 1 438 1700.
-
What is Medtronic stock forecast & price target?
Based on 10 Wall Street analysts` predicted price targets for Medtronic in the last 12 months, the avarage price target is $95.4. The average price target represents a 6.03% change from the last price of $89.97.
Medtronic company profile:
Medtronic plc
medtronic.comExchange:
NYSE
Full time employees:
95,000
Industry:
Medical - Devices
Sector:
Healthcare
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
20 On Hatch
Dublin, 2
Dublin, 2
CIK: 0001613103
ISIN: IE00BTN1Y115
CUSIP: G5960L103
